首页|期刊导航|中国当代医药|基于网络药理、分子对接和分子动力学模拟分析芍药苷治疗高血压肾病的机制

基于网络药理、分子对接和分子动力学模拟分析芍药苷治疗高血压肾病的机制OA

Mechanism of paeoniflorin in the treatment of hypertensive nephropathy based on network pharmacology,molecular docking,and molecular dy-namics simulation

中文摘要英文摘要

目的 探讨芍药苷干预高血压肾病的潜在作用及其机制.方法 通过中医药系统药理学数据库与分析平台(TCMSP)、Pubchem、SwissTargetPrediction获取芍药苷的靶点,结合GeneCards、OMIM及DisGeNET数据库获取高血压肾病相关基因;采用韦恩图筛选关键交集靶点,运用STRING构建蛋白质互作网络,并基于CytoScape网络拓扑分析确定核心靶点.通过DAVID数据库进行GO功能与KEGG通路富集分析,并运用分子对接技术与分子动力学模拟验证芍药苷与关键靶点的结合活性与稳定性.结果 筛选出芍药苷治疗高血压肾病潜在靶点 21 个;对交集靶点进行GO和KEGG富集分析发现,芍药苷可能通过调节脂质和动脉粥样硬化、AGE-RAGE、MAPK、PI3K-Akt等信号通路发挥作用;分子对接结果显示,芍药苷与核心靶点IL-6、TNF、LGALS3 和FGF2 具有稳定结合能力;分子动力学模拟进一步证实,芍药苷与IL-6、TNF结合稳定性较好.结论 芍药苷可能通过抑制IL6/TNF介导的炎症级联反应延缓高血压肾病的发展.

Objective To investigate the potential effect and mechanism of paeoniflorin in intervening hypertensive nephropathy.Methods The main targets of paeoniflorin were screened via Traditional Chinese Medicine Systems Phar-macology(TCMSP)and SwissTargetPrediction databases,while hypertensive nephropathy-related genes were obtained from GeneCards,OMIM,and DisGeNET databases.The intersection targets were identified using Venn diagrams.A protein-protein interaction(PPI)network was constructed using STRING,and key targets were determined through topological analysis with Cytoscape.GO functional and KEGG pathway enrichment analyses were conducted through the DAVID database,and the binding activity and stability of paeoniflorin with key targets were verified by molecular docking technology and molecular dynamics simulation.Results Twenty-one potential targets of paeoniflorin in the treatment of hypertensive nephropathy were screened out.GO and KEGG enrichment analysis of the intersection targets revealed that paeoniflorin might exert its effects by regulating lipid and atherosclerosis,AGE-RAGE,MAPK,PI3K-Akt and other signaling pathways.Molecular docking results showed that paeoniflorin had stable binding ability with core targets IL-6,TNF,LGALS3 and FGF2.Molecular dy-namics simulation further confirmed that the binding stability of paeoniflorin with IL-6 and TNF was good.Conclusion Paeoniflorin may ameliorate the progression of hypertensive nephropathy by inhibiting IL-6/TNF-medi-ated inflammatory cascades.

王维帅;贾伟伟;赵红晔;王月飞;卢长柱;吕莹;王玉阁;肖宇

齐齐哈尔医学院基础医学院,黑龙江 齐齐哈尔 161006齐齐哈尔医学院基础医学院,黑龙江 齐齐哈尔 161006齐齐哈尔医学院基础医学院,黑龙江 齐齐哈尔 161006齐齐哈尔医学院基础医学院,黑龙江 齐齐哈尔 161006齐齐哈尔医学院基础医学院,黑龙江 齐齐哈尔 161006齐齐哈尔医学院基础医学院,黑龙江 齐齐哈尔 161006齐齐哈尔医学院基础医学院,黑龙江 齐齐哈尔 161006齐齐哈尔医学院基础医学院,黑龙江 齐齐哈尔 161006

医药卫生

芍药苷高血压肾病网络药理学分子对接分子动力学模拟

PaeoniflorinHypertensive nephropathyNet-work pharmacologyMolecular dockingMolecular dynamics simulation

《中国当代医药》 2026 (4)

4-8,5

黑龙江省自然科学基金项目(LH2022C105)黑龙江省省属高等学校基本科研业务费科研项目(2022-KYYWF-0832)齐齐哈尔医学科学院重点培育项目(2022-ZDPY-009)齐齐哈尔医学院重点学科建设项目(QYZDXK-005).

10.3969/j.issn.1674-4721.2026.04.01

评论